News & Announcements
Assistant Dean at Temple University School of Medicine Selected One of Region's Most Influential Latinos
Raul A. DeLa Cadena, MD, Assistant Dean and Director of the Recruitment, Admissions and Retention (RAR) Program at Temple University School of Medicine, has been selected as one of the "Delaware Valley's Most Influential Latinos" for 2012. He was selected for the honor by the Most Influential Latinos Foundation, whose stated mission is to support and encourage Latino leadership and empowerment. Dr. DeLa Cadena will be recognized, along with the other honorees, at a Gala Dinner and celebration on November 29 in Philadelphia.
"This is a great honor for which I am pleased to be recognized," said Dr. DeLa Cadena. "It is also a reflection on Temple University School of Medicine's proud legacy of helping disadvantaged students overcome academic and economic obstacles that contribute to their underrepresentation among our nation's physicians."
As Director of Temple's RAR Program, Dr. DeLa Cadena works to enhance the recruitment of underrepresented minorities to the School of Medicine. The primary purpose of the RAR Program is to help Temple identify, enroll, retain and graduate physicians from such backgrounds to infuse diversity into the healthcare workforce in the profession of medicine both regionally and nationally.
"This selection of Dr. DeLa Cadena as one of the region's most influential Latinos is well deserved," said Arthur M. Feldman, MD, PhD, Executive Dean of Temple University School of Medicine. "Dr. DeLa Cadena works tirelessly to help Temple actualize its commitment to diversity in its student body, while also maintaining excellence in its academic programs."
Dr. DeLa Cadena also serves as Professor of Physiology and holds a faculty appointment at Temple's Sol Sherry Thrombosis Research Center. His research focuses on the pathophysiology of Diabetic Retinopathy and Rheumatoid Arthritis.
Date Published: Wednesday, November 21, 2012
back | view all news
Temple Among First in Region to Offer New Cardiac Monitors
Temple is among the first in the region to offer Medtronic's Reveal LINQ Insertable Cardiac Monitor (ICM) System®, the smallest implantable cardiac monitoring device available for patients.
read more »
Fox Chase Cancer Center Treating Lymphedema with Innovative Surgical Procedure
An innovative transplant surgery called Vascularized Lymph Node Transfer is now being offered at Fox Chase Cancer Center.
read more »
Temple University Hospital Using Novel Stent Technology to Remove Brain Clots
Temple University Hospital is the only hospital in Philadelphia participating in an international clinical trial to evaluate the effectiveness of a device called a "stentriever" to remove brain-damaging clots that are causing a stroke.
read more »